comparemela.com

Latest Breaking News On - Life sciencesnv nasdaq - Page 3 : comparemela.com

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day

Investegate announcements from atai Life Sciences, atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day

New yorkUnited statesSan franciscoStephen bardinAllan malievskyExchange commissionLife sciencesnv nasdaqLife sciencesLife sciences virtual rd dayOctober investor eventsInaugural healthcare opportunities conferenceRoth inaugural healthcare opportunitiesPsychiatry conferenceCantor fitzgeraldPrivate securities litigation reform actAnnual report

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences to Participate in September Investor Events

Investegate announcements from atai Life Sciences, atai Life Sciences to Participate in September Investor Events

New yorkUnited statesStephen bardinAllan malievskyExchange commissionIndustry panelLife sciencesnv nasdaqLife sciencesCompany presentationSeptember investorAnnual biopharma conferenceAnnual global investment conferenceAnnual novel mechanismsNeuropsychiatry virtualEmerging novel treatmentsMental health summit

atai Life Sciences to Participate in September Investor Events

NEW YORK and BERLIN, Sept. 07, 2022 (GLOBE NEWSWIRE) atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders

New yorkUnited statesStephen bardinAllan malievskyExchange commissionIndustry panelLife sciencesnv nasdaqLife sciencesCompany presentationAnnual biopharma conferenceAnnual global investment conferenceAnnual novel mechanismsNeuropsychiatry virtualEmerging novel treatmentsMental health summitPrivate securities litigation reform act

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update

Investegate announcements from atai Life Sciences, atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update

Chad beyerKabir nathStephen bardinMario saltarelliSrinivas raoAllan malievskyGlobal pharmaceuticals at otsukaTeam expansionLife sciences reports second quarterRecognify life sciencesExchange commissionLife sciencesnv nasdaqViridia life sciencesLife sciencesSecurities exchangeHercules capital inc

atai Life Sciences Secures Term Loan Facility for up to $175 Million from Hercules Capital

- Non-dilutive financing facility, plus $312M existing cash on hand as of June 30, 2022, gives atai access to up to $487M to continue developing next generation mental health treatments -. | August 15, 2022

Michael dutraStephen bardinJanice bourqueLatham watkinsAllan malievskyMorrison foerster llpExchange commissionLife sciencesnv nasdaqLife sciencesSecurities exchangeHercules capital incMorrison foersterHercules capitalFlorian brandChief executive officerManaging director

vimarsana © 2020. All Rights Reserved.